Matrix Trust Company’s Argan AGX Stock Holding History

Matrix Trust Company’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52	Closed	-$28K	–	105
2026 Q1	$28K	Buy	52 +5	+11%	+$2.04K	﹤0.01%	95
2025 Q4	$15K	Hold	47	–	–	﹤0.01%	174
2025 Q3	$13K	Buy	+47	New	+$10.8K	﹤0.01%	224

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Matrix Trust Company's AGX Position: Q2 2026 in Review

Matrix Trust Company sold out of Argan (AGX) in Q2 2026, closing a stake of 52 shares — an estimated $28K sold.

Matrix Trust Company first reported a position in AGX in Q3 2025 and held it in 3 quarters. The position peaked at $28K in Q1 2026. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

Matrix Trust Company reported no remaining Argan position as of Q2 2026 after selling out during the quarter.
Matrix Trust Company sold 52 Argan shares in Q2 2026, an estimated $28K.
Matrix Trust Company first reported a position in Argan in Q3 2025 and held it in 3 quarters.
Matrix Trust Company's Argan position peaked at $28K in Q1 2026.
562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Matrix Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.